Lawmakers in both parties view simmering fury over the cost of living as the top issue in next year’s midterm elections and are pitching a growing profusion of proposals to tackle the notoriously difficult problem of affordability.
Lawmakers can meet until mid-March during a non-budget year, but plan to adjourn early to offset the two weeks they spent this month on a failed partisan redistricting proposal.
Despite Thursday’s positive forecasts, Republican state fiscal leaders showed no signs of any spending boosts for the tight budget that took effect July 1.
Reclassification by the Drug Enforcement Administration would not make it legal for recreational use by adults nationwide, but it could change how the drug is regulated and reduce a hefty tax burden on the cannabis industry.
Indiana health officials are extending open enrollment for two major Medicaid programs, giving more time for hundreds of thousands of Hoosiers facing a forced plan change to select another option from the state’s managed care lineup.
Critics of redistricting, including former Indianapolis Mayor Greg Ballard, say the city’s interests aren’t likely to be a top priority for elected officials in the proposed new congressional districts.
During William Retherford’s tenure, both companies have received recognition from outside organizations, including the 2023 U.S. Environmental Protection Agency Administration Award for Outstanding Accomplishments by a Service-Disabled Veteran-Owned Small Business.
Indiana House Democrats on Monday decried the drafted maps as an “egregious gerrymander” and attempted multiple procedural maneuvers to prevent the legislative session from starting.
The Indianapolis-based drugmaker said the coverage would be administered by third-party administrators to provide employers “transparent, flexible cost-sharing options” for their workers.
The plan is described as a “collaborative effort” to be jointly led by the Indiana Family and Social Services Administration and the Indiana Department of Health.
Republican Indiana legislative leaders avoided taking questions Monday about the political pressure they are facing from President Donald Trump over congressional redistricting, while the governor accused GOP senators of “hiding behind closed doors.”
Meeting Monday for the Indiana Chamber Legislative Preview event, Statehouse leaders addressed what the Legislature is likely to consider during the upcoming General Assembly.
As GLP-1 drugs for weight loss and diabetes drugs such as Zepbound and Mounjaro generate billions in sales, researchers at Eli Lilly and Co. and other pharma companies are exploring their potential for other purposes.
Indianapolis-based MDwise, which said it has provided Indiana Medicaid services for more than 30 years, has already launched a court challenge to the state’s action.
Recovery programs like Dove House exist within an interconnected system of health, workforce and community outcomes. When access to one part of that system erodes, the others inevitably feel the impact.
Thursday’s announcement is the latest attempt by the Trump administration to rein in soaring drug prices in its efforts to address cost-of-living concerns among voters.
